Clinical Trials Directory

Trials / Completed

CompletedNCT00843362

24-Hour Vaginal Dinoprostone Pessary Versus Gel for Labour Induction

A Randomised Controlled Trial of 24-Hours Vaginal Dinoprostone Pessary vs. Gel for Induction of Labour in Term Pregnancies With a Bishop Score ≤4

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
133 (actual)
Sponsor
Università degli Studi di Brescia · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of induction of labour is to initiate labour when maternal and fetal conditions necessitate delivery before the onset of spontaneous contractions. Prostaglandins are widely used for induction of labour, and can be administered orally, vaginally, intracervically, endovenously and by extra-amniotic or intra-amniotic routes. Dinoprostone is one of the synthetic prostaglandins most commonly used to achieve cervical ripening and labour induction, and can be administered as tablets, suppositories, gel (vaginal and intracervical) or as a controlled-release intravaginal pessary. The controlled-release pessary has some potential advantages: a single application is required; the insert is easily administered and can be removed as soon as labour starts or if complications ensue. Studies comparing the dinoprostone vaginal insert to other prostaglandin formulations have shown variable results, probably influenced by drug administration regimens, indications for induction, and cervical conditions of the women. The purpose of this study is to assess the efficacy of the induction of labour using dinoprostone in patients with an unfavourable cervix, and to compare the efficacy and the cost of 24-hours controlled-release dinoprostone pessary and intravaginal dinoprostone gel.

Conditions

Interventions

TypeNameDescription
DRUGDinoprostone vaginal pessary10 mg controlled-release dinoprostone pessary applied for 24 hours
DRUGDinoprostone vaginal gel2 mg vaginal dinoprostone gel, two daily doses with a 6 hours interval

Timeline

Start date
2006-12-01
Primary completion
2008-03-01
Completion
2008-06-01
First posted
2009-02-13
Last updated
2009-02-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00843362. Inclusion in this directory is not an endorsement.